Copyright © 2024 · Alle Rechte vorbehalten. · Genome Editing INFOTHEK
Gemeinnützige Website von GivingPress · RSS-Feed · Anmelden
Cookie | Dauer | Beschreibung |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Schlagwort: EKD; Konrad Adenauer-Stiftung; Zulassung
Zulassung neuer genomischer Techniken
Geschrieben am 26. Februar 2024 von sas
Öffnung der Büchse der Pandora oder Zukunftschance? Online-Veranstaltung EKD Brüssel/Konrad Adenauer-Stiftung e.V. Europabüro, Dienstag, 19. März 12:30-14:00h weiterlesen bei kas.de
Kategorie: Meinungen+Meldungen, News/Allgemein, Veranstaltungen Tags: EKD; Konrad Adenauer-Stiftung; Zulassung
UPDATE